drugset / Trial / NCT02136316

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects

NCT02136316

Phase 1 Completed 48 enrolled Astellas Pharma Europe B.V.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate the safety and tolerability as well as the pharmacokinetics of increasing oral multiple doses of ASP7962 in healthy young male and female subjects.

Timeline

Start
2014-05
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP7962 Small molecule Oral

Indications

No indication recorded.